According to the report, the global smart pills market was approximately USD 860 million in 2018 and is expected to generate around USD 1,503 million by 2025, at a CAGR of around 8.3% between 2019 and 2025.
New York, NY, June 12, 2019 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Smart Pills Market by Component (Smart Pills and Workstations), by Application (Imaging and Monitoring), and by End-User (Hospitals, Clinics, Research Institutes, and Home Healthcare): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global smart pills market was approximately USD 860 million in 2018 and is expected to generate around USD 1,503 million by 2025, at a CAGR of around 8.3% between 2019 and 2025.
Smart pills are revolutionary technological innovations that have reduced the gap between digital technology and healthcare. Smart pills are basically small-embedded electronic appliances or medical devices that are embedded with cameras, sensors, and trackers. These electronic devices can be easily swallowed, as they provide a complete evaluation of the gastrointestinal monitoring tract. The advent of these healthcare-cum-technology devices has addressed the soaring needs for better diagnosis and monitoring.
Browse through 54 Tables & 26 Figures spread over 110 Pages and in-depth TOC on “Global Smart Pills Market: Size, Share, Trends, Segments, Analysis and Forecast, 2018–2025”.
Request Free Sample Report of Global Smart Pills Market Report @ https://www.zionmarketresearch.com/sample/smart-pills-market
The growing prevalence of chronic gastrointestinal illnesses is driving the smart pills market globally, as these are more efficient in diagnosing these diseases. Additionally, the changing lifestyle also includes a shift in the dietary patterns, which is also boosting the smart pills market globally. Similarly, the rising disposable income of the population in developing countries of the Asia Pacific is further propelling this market, owing to its affordability. Furthermore, there has also been a noticeable shift of patients from hospitals to home care settings. Many patients require constant health monitoring and prefer the comforts of home healthcare monitoring over the costly and inconvenient hospital care, which is further boosting the market growth for smart pills.
The component segment of the global smart pills market includes workstation and smart pills (capsule endoscopy and patient monitoring). The capsule endoscopy segment further includes esophagus endoscopy, small bowel endoscopy, and colon endoscopy. The smart pills segment held a major market share in 2018. Diagnostic devices or sensor embedded systems support the monitoring of vital parameters like pH, pulse rate, temperature, and other signs in the comfort zone of the patient.
Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/smart-pills-market
On the basis of application, the smart pills market is bifurcated into patient monitoring and imaging. The patient monitoring segment is likely to grow at the fastest rate in the future.
By end-user, the smart pills market includes clinics, hospitals, home healthcare, and research institutes. Hospitals held a major market share in terms of revenue in 2018. Additionally, the home healthcare segment is likely to register the highest CAGR over the forecast time period, owing to its convenience to the patients.
Browse the full “Smart Pills Market by Component (Smart Pills and Workstations), by Application (Imaging and Monitoring), and by End-User (Hospitals, Clinics, Research Institutes, and Home Healthcare): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/smart-pills-market
North America is likely to dominate the global smart pills market over the forecast time period, owing to the growing of non-invasive treatments in the U.S. and Canada, favorable reimbursement policies, FDA approvals for smart pills, and rising investments by government and private agencies.
Europe is the second leading regional market for smart pills and is likely to show significant growth in the upcoming years. Increasing count of the elderly population in the European nations and rising investments made in Austria along with a large number of endoscopy training workshops are boosting the European smart pills market.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/smart-pills-market
The Asia Pacific smart pills market is relatively new to the smart pills technology, but the rising support for endoscopy research, growing investments by corporate players, and changing reimbursement scenario across the region is likely to drive the growth of the smart pill technology in the Asia Pacific.
Latin America is an important regional market for smart pills, which is expected to experience moderate growth over the forecast time period. In the Middle East and Africa, the African region is projected to register noticeable growth due to increased government funding and growing healthcare expenditure.
Some leading players in the global smart pills market include Proteus Digital Health, Check-Cap, Body-Cap Medical, CapsoVision, Medimetrics, Given Imaging, Chongqing Jinshan Science and Technology, IntroMedic, Olympus Corporation, and Philips Respironics.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/1193
This report segments the global smart pills market into:
Global Smart Pills Market: By Component
- Smart Pills
- Patient Monitoring
- Capsule Endoscopy
- Small Bowel Endoscopy
- Esophagus Endoscopy
- Colon Endoscopy
Global Smart Pills Market: By Application
Global Smart Pills Market: By End-User
- Research Institutes
- Home Healthcare
Global Smart Pills Market: By Region
- North America
- The U.S.
- Asia Pacific
- Latin America
- The Middle East and Africa
More Related Reports:
- Immuno Oncology Assays Market: https://www.zionmarketresearch.com/report/immuno-oncology-assays-market
- Pharmacovigilance Market: https://www.zionmarketresearch.com/report/pharmacovigilance-market
- Liquid Biopsy Market: https://www.zionmarketresearch.com/report/global-liquid-biopsy-market
- Rheumatoid Arthritis Drugs Market: https://www.zionmarketresearch.com/report/rheumatoid-arthritis-drugs-market
- Pharmacovigilance and Drug Safety Software Market: https://www.zionmarketresearch.com/report/pharmacovigilance-drug-safety-software-market
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: [email protected]
Latest posts by GlobeNewswire (see all)
- CTI CEO Mo Kasti leading speakers panels at Physician Practice Transformation Summit - August 20, 2019
- LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In NetApp, Inc. To Contact The Firm - August 20, 2019
- SASOL INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Sasol Limited To Contact The Firm - August 20, 2019